ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009